1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of CXCL13 mRNA CTD PMID:27840820 1,2-dimethylhydrazine increases expression ISO RGD:1556887 6480464 1, 2-Dimethylhydrazine results in increased expression of CXCL13 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of CXCL13 mRNA CTD PMID:25380136 , PMID:30723492 1-nitropyrene decreases expression ISO RGD:1342514 6480464 1-nitropyrene results in decreased expression of CXCL13 mRNA CTD PMID:19428942 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL13 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL13 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1342514 6480464 [Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CXCL13 mRNA, Tetrachlorodibenzodioxin promotes the reaction [[AHR protein binds to RELB protein] which binds to CXCL13 promoter] CTD PMID:17900530 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CXCL13 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1556887 6480464 Tetrachlorodibenzodioxin affects the expression of CXCL13 mRNA CTD PMID:26377647 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1342514 6480464 Tetrachlorodibenzodioxin results in decreased expression of CXCL13 mRNA CTD PMID:20106945 , PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1342514 6480464 Tetrachlorodibenzodioxin affects the expression of CXCL13 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CXCL13 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of CXCL13 mRNA] CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1556887 6480464 Tetrachlorodibenzodioxin results in increased expression of CXCL13 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1556887 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CXCL13 promoter] CTD PMID:19654925 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1556887 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CXCL13 mRNA CTD PMID:15973123 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of CXCL13 mRNA CTD PMID:20409345 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of CXCL13 mRNA CTD PMID:28522335 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of CXCL13 mRNA CTD PMID:25380136 7,12-dimethyltetraphene affects expression ISO RGD:1556887 6480464 9 more ... CTD PMID:21785161 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of CXCL13 mRNA CTD PMID:28959563 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CXCL13 mRNA CTD PMID:23630614 more ... aflatoxin B1 decreases expression ISO RGD:1342514 6480464 Aflatoxin B1 results in decreased expression of CXCL13 mRNA CTD PMID:32234424 andrographolide multiple interactions ISO RGD:1556887 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CXCL13 mRNA CTD PMID:19737545 antirheumatic drug decreases expression ISO RGD:1342514 6480464 Antirheumatic Agents results in decreased expression of CXCL13 mRNA CTD PMID:24449571 asperentin increases expression ISO RGD:1556887 6480464 cladosporin results in increased expression of CXCL13 mRNA CTD PMID:19818335 benzo[a]pyrene decreases expression ISO RGD:1342514 6480464 Benzo(a)pyrene results in decreased expression of CXCL13 mRNA CTD PMID:20106945 benzo[a]pyrene multiple interactions ISO RGD:1556887 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL13 mRNA CTD PMID:27858113 benzo[a]pyrene increases methylation ISO RGD:1342514 6480464 Benzo(a)pyrene results in increased methylation of CXCL13 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CXCL13 mRNA CTD PMID:21839799 benzo[a]pyrene decreases expression ISO RGD:1556887 6480464 Benzo(a)pyrene results in decreased expression of CXCL13 mRNA CTD PMID:19770486 benzo[b]fluoranthene multiple interactions ISO RGD:1556887 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL13 mRNA CTD PMID:27858113 Benzo[k]fluoranthene increases expression ISO RGD:1556887 6480464 benzo(k)fluoranthene results in increased expression of CXCL13 mRNA CTD PMID:26377693 beta-naphthoflavone multiple interactions ISO RGD:1556887 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of CXCL13 mRNA CTD PMID:19737545 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1556887 6480464 Diethylhexyl Phthalate results in increased expression of CXCL13 mRNA CTD PMID:28085963 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CXCL13 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CXCL13 mRNA CTD PMID:33296240 bleomycin A2 affects expression ISO RGD:1556887 6480464 Bleomycin affects the expression of CXCL13 mRNA CTD PMID:26345256 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of CXCL13 mRNA CTD PMID:32479839 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CXCL13 mRNA CTD PMID:25993096 carbamazepine affects expression ISO RGD:1342514 6480464 Carbamazepine affects the expression of CXCL13 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1556887 6480464 Nanotubes, Carbon results in increased expression of CXCL13 mRNA CTD PMID:25554681 , PMID:25620056 carbon nanotube increases expression ISO RGD:1342514 6480464 Nanotubes, Carbon results in increased expression of CXCL13 mRNA CTD PMID:29348435 carbon nanotube affects expression ISO RGD:1556887 6480464 Nanotubes, Carbon analog affects the expression of CXCL13 mRNA CTD PMID:25554681 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of CXCL13 mRNA CTD PMID:18500788 CGP 52608 multiple interactions ISO RGD:1342514 6480464 CGP 52608 promotes the reaction [RORA protein binds to CXCL13 gene] CTD PMID:28238834 choline multiple interactions ISO RGD:1556887 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of CXCL13 protein, PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in increased expression of CXCL13 protein] CTD PMID:29246445 chrysene multiple interactions ISO RGD:1556887 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL13 mRNA CTD PMID:27858113 ciguatoxin CTX1B affects expression ISO RGD:1556887 6480464 Ciguatoxins affects the expression of CXCL13 mRNA CTD PMID:18353800 cyclosporin A decreases expression ISO RGD:1342514 6480464 Cyclosporine results in decreased expression of CXCL13 mRNA CTD PMID:20106945 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of CXCL13 mRNA CTD PMID:21865292 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of CXCL13 mRNA CTD PMID:23640034 dextran sulfate increases expression ISO RGD:1556887 6480464 Dextran Sulfate results in increased expression of CXCL13 mRNA CTD PMID:23894361 , PMID:35093514 dibutyl phthalate affects expression EXP 6480464 Dibutyl Phthalate affects the expression of CXCL13 mRNA CTD PMID:30934153 diclofenac increases expression ISO RGD:1556887 6480464 Diclofenac results in increased expression of CXCL13 mRNA CTD PMID:26934552 doxorubicin increases expression ISO RGD:1556887 6480464 Doxorubicin results in increased expression of CXCL13 mRNA CTD PMID:28608983 epoxiconazole increases expression ISO RGD:1556887 6480464 epoxiconazole results in increased expression of CXCL13 mRNA CTD PMID:35436446 furan increases expression EXP 6480464 furan results in increased expression of CXCL13 mRNA CTD PMID:27387713 genistein increases expression ISO RGD:1556887 6480464 Genistein results in increased expression of CXCL13 mRNA CTD PMID:32186404 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CXCL13 mRNA CTD PMID:33387578 graphene oxide increases expression ISO RGD:1556887 6480464 graphene oxide results in increased expression of CXCL13 mRNA CTD PMID:33227293 iron(2+) sulfate (anhydrous) decreases expression ISO RGD:1342514 6480464 ferrous sulfate results in decreased expression of CXCL13 mRNA CTD PMID:19428942 isoprenaline increases expression ISO RGD:1556887 6480464 Isoproterenol results in increased expression of CXCL13 mRNA CTD PMID:20003209 lidocaine decreases expression EXP 6480464 Lidocaine results in decreased expression of CXCL13 mRNA CTD PMID:35283115 lipopolysaccharide increases expression ISO RGD:1556887 6480464 Lipopolysaccharides results in increased expression of CXCL13 mRNA CTD PMID:19136613 , PMID:27339419 metformin decreases expression EXP 6480464 Metformin results in decreased expression of CXCL13 mRNA CTD PMID:31324951 methylmercury chloride increases expression ISO RGD:1342514 6480464 methylmercuric chloride results in increased expression of CXCL13 mRNA CTD PMID:28001369 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of CXCL13 mRNA CTD PMID:31378766 mifepristone decreases expression ISO RGD:1342514 6480464 Mifepristone results in decreased expression of CXCL13 mRNA CTD PMID:17584828 mycotoxin increases expression ISO RGD:1556887 6480464 Mycotoxins results in increased expression of CXCL13 mRNA CTD PMID:19818335 N,N-diethyl-m-toluamide increases expression ISO RGD:1342514 6480464 DEET results in increased expression of CXCL13 mRNA CTD PMID:27091632 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of CXCL13 mRNA CTD PMID:25380136 neoechinulin A decreases expression ISO RGD:1556887 6480464 neoechinulin A results in decreased expression of CXCL13 mRNA CTD PMID:19818335 nickel dichloride multiple interactions ISO RGD:1342514 6480464 nickel chloride inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CXCL13 mRNA] CTD PMID:23090859 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of CXCL13 mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO RGD:1342514 6480464 methyleugenol results in decreased expression of CXCL13 mRNA CTD PMID:32234424 ozone multiple interactions ISO RGD:1556887 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CXCL13 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:1342514 6480464 Acetaminophen results in increased expression of CXCL13 mRNA CTD PMID:26690555 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CXCL13 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1342514 6480464 Acetaminophen results in decreased expression of CXCL13 mRNA CTD PMID:29067470 phenobarbital decreases expression ISO RGD:1556887 6480464 Phenobarbital results in decreased expression of CXCL13 mRNA CTD PMID:19270015 pirinixic acid multiple interactions ISO RGD:1556887 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CXCL13 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1556887 6480464 pirinixic acid results in decreased expression of CXCL13 mRNA CTD PMID:17426115 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of CXCL13 mRNA CTD PMID:28374803 serpentine asbestos increases expression ISO RGD:1342514 6480464 Asbestos, Serpentine results in increased expression of CXCL13 mRNA CTD PMID:33581214 silicon dioxide decreases expression ISO RGD:1342514 6480464 Silicon Dioxide results in decreased expression of CXCL13 mRNA CTD PMID:19428942 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CXCL13 mRNA CTD PMID:22431001 , PMID:32721576 sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of CXCL13 mRNA CTD PMID:21865292 sodium arsenite decreases expression ISO RGD:1556887 6480464 sodium arsenite results in decreased expression of CXCL13 mRNA CTD PMID:21911445 sodium arsenite decreases expression ISO RGD:1342514 6480464 sodium arsenite results in decreased expression of CXCL13 mRNA CTD PMID:29301061 sodium arsenite affects methylation ISO RGD:1342514 6480464 sodium arsenite affects the methylation of CXCL13 gene CTD PMID:28589171 sodium arsenite increases expression ISO RGD:1556887 6480464 sodium arsenite results in increased expression of CXCL13 mRNA CTD PMID:21911445 sodium arsenite increases expression ISO RGD:1342514 6480464 sodium arsenite results in increased expression of CXCL13 mRNA CTD PMID:17879257 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of CXCL13 mRNA CTD PMID:25993096 sterigmatocystin increases expression ISO RGD:1556887 6480464 Sterigmatocystin results in increased expression of CXCL13 mRNA CTD PMID:19818335 succimer multiple interactions ISO RGD:1342514 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL13 mRNA CTD PMID:26378955 succimer multiple interactions ISO RGD:1556887 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL13 mRNA CTD PMID:26378955 sunitinib decreases expression ISO RGD:1556887 6480464 Sunitinib results in decreased expression of CXCL13 mRNA CTD PMID:27560553 taurocholic acid multiple interactions ISO RGD:1556887 6480464 EGR1 promotes the reaction [Taurocholic Acid results in increased expression of CXCL13 mRNA] CTD PMID:21224055 taurocholic acid increases expression ISO RGD:1556887 6480464 Taurocholic Acid results in increased expression of CXCL13 mRNA CTD PMID:21224055 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CXCL13 mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO RGD:1556887 6480464 Carbon Tetrachloride results in increased expression of CXCL13 mRNA CTD PMID:27339419 tetraphene multiple interactions ISO RGD:1556887 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of CXCL13 mRNA CTD PMID:27858113 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CXCL13 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1556887 6480464 titanium dioxide results in increased expression of CXCL13 mRNA CTD PMID:23131501 , PMID:23557971 tofacitinib decreases expression ISO RGD:1342514 6480464 tofacitinib results in decreased expression of CXCL13 mRNA CTD PMID:25398374 toluene 2,4-diisocyanate decreases expression ISO RGD:1556887 6480464 Toluene 2, 4-Diisocyanate results in decreased expression of CXCL13 mRNA CTD PMID:21404309 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CXCL13 mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO RGD:1556887 6480464 trimellitic anhydride results in increased expression of CXCL13 mRNA CTD PMID:16141432 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of CXCL13 mRNA CTD PMID:23160963 zinc dichloride decreases expression ISO RGD:1342514 6480464 zinc chloride results in decreased expression of CXCL13 mRNA CTD PMID:19428942
